retinal diseases

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka

Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka…

by Timos Papagatsias

AAVs under threat

Are AAVs really under threat? 

Gene therapies can be the answer to treating, preventing, or curing various…

by Eugenia Tsempera

Gene Therapy for IRDs

Gene therapy treatments for Inherited Retinal Disorders (IRD) hold great promise. 

Globally 4.5 million people are affected by IRDs — a group of diseases having a…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.